Today techs MannKind Company to Take part within the Lytham Companions

today techs

today techs itemprop=”articleBody”>

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 21, 2022 (GLOBE NEWSWIRE) — MannKind Company (Nasdaq: MNKD)an organization targeted on the event and commercialization of progressive therapeutic merchandise for sufferers with endocrine and orphan lung illnesses, introduced right now that its Chief Govt Officer, Michael Castagna, PharmD, will take part within the Lytham Companions Fall 2022 Investor Convention going down today techs nearly on September 28-29, 2022.

The Firm’s webcast presentation might be obtainable for viewing at 9:00am ET on Wednesday, September 28, 2022, on the Firm’s web site at Occasions & Shows or https://buyers.mannkindcorp.com/events-and-presentations. The webcast will even be archived and obtainable for replay.

Administration might be collaborating in digital one-on-one conferences all through the occasion. To rearrange a gathering with administration, please contact Lytham Companions at 1×1@lythampartners.com.

About MannKind Company

MannKind Company (Nasdaq: MNKD) focuses on the event and commercialization of progressive therapeutic merchandise and gadgets to deal with critical unmet medical wants for these residing with endocrine and orphan lung illnesses.

We’re dedicated to utilizing our formulation capabilities and system engineering prowess to reduce the burden of illnesses similar to diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung illness. Our signature applied sciences – dry-powder formulations and inhalation gadgets – provide fast and handy supply of medicines to today techs the deep lung the place they will exert an impact domestically or enter the systemic circulation.

With a passionate staff of Mannitarians collaborating nationwide, we’re on a mission to present individuals management of their well being and the liberty to dwell life.

Please go to mannkindcorp.com to study extra, and comply with us on LinkedIn, Fb, Twitter or Instagram.

Firm Contact:
Rose Alinaya, Investor Relations
(818) 661-5000
E mail: ir@mannkindcorp.com

today techs
today techs
today techs today techs

Be the first to comment

Leave a Reply

Your email address will not be published.


*